Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

Retail chatter around Klotho Neurosciences picked up late Thursday after the company said that the FDA had granted Orphan Drug Designation to its ALS gene therapy candidate, KLTO-202. The designation ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.

"ALS may be considered a rare disease, but it's actually more common than people think, affecting 1 in 300 Americans. It can strike anyone at anytime and is always fatal," Brian Frederick, ...

New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking approval for an experimental medication for the neurological condition.

Without knowing what causes ALS, it’s difficult to tell why some people develop the disease while others do not. Risk factors may be genetic and related to environmental factors. Learn more ...

ALS is a cruel disease. It gradually robs a person's body of its motor skills until the ability to walk, talk, stand and eat are gone. About 5,000 people in the U.S. are diagnosed every year ...